Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2000
03/16/2000WO2000014217A2 G-motif oligonucleotides and uses thereof
03/16/2000WO2000014204A1 Nerve cell death receptor
03/16/2000WO2000014119A2 Bifunctional antibodies and their use in targeting anti-tumour agents
03/16/2000WO2000014114A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
03/16/2000WO2000014112A2 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby
03/16/2000WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000WO2000013705A1 Use of tgf-beta inhibitors for treating cerebral disorders
03/16/2000WO2000013704A1 Formulation of nucleic acids and acemannan
03/16/2000WO2000013703A2 Methods of treating hypertension and compositions for use therein
03/16/2000WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies
03/16/2000WO2000013699A1 An antigenic peptide encoded by an alternative open reading frame of human macrophage colony-stimulating factor
03/16/2000WO2000013677A1 Nanogel networks and biological agent composition thereof
03/16/2000WO2000006694A3 Compound and method for the prevention and/or the treatment of allergy
03/16/2000WO2000002897A3 Delta cleavage products and methods based thereon
03/16/2000WO2000002582A3 Treatment of celiac disease with interleukin-15 antagonists
03/16/2000WO2000000628B1 Replication-defective recombinant adenovirus with mutated major late promoter
03/16/2000WO2000000216A3 Use of poxviruses as enhancer of specific immunity
03/16/2000WO1999066953A3 Coccidiosis vaccine, method for the production thereof, and the use thereof
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063941A3 Novel hepatitis c virus peptides and uses thereof
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/16/2000WO1999062939A3 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999058611A3 Process for extracting carotenes from carotene-containing materials
03/16/2000WO1999058570A3 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
03/16/2000WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
03/16/2000CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000CA2342800A1 Nanogel networks and biological agent composition thereof
03/16/2000CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000CA2342208A1 Use of tgf-beta inhibitors for treating cerebral disorders
03/16/2000CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000CA2341777A1 Neutral amino acid transporter and gene thereof
03/16/2000CA2341753A1 Bifunctional antibodies and their use in targeting anti-tumour agents
03/16/2000CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
03/16/2000CA2341338A1 G-motif oligonucleotides and uses thereof
03/16/2000CA2341302A1 Lim domain protein homolog
03/16/2000CA2338384A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
03/16/2000CA2308444A1 Formulation of nucleic acids and acemannan
03/15/2000EP0985729A2 Streptokinase mutants
03/15/2000EP0985044A1 Anti-cancer vaccine
03/15/2000EP0985037A1 Human multiple endocrine neoplasia type 1 protein
03/15/2000EP0985036A1 Zinc ring protein
03/15/2000EP0984985A2 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis
03/15/2000EP0984790A1 Herpes simplex virus vp22 vaccines and methods of use
03/15/2000EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
03/15/2000EP0648279B1 Acceptor for fucosyltransferase
03/15/2000EP0610286B1 Recombinant immunotoxins
03/15/2000EP0563311B1 Improved vaccines
03/15/2000EP0506785B1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247472A Treatment of lupus nephritis with anti-CD40L compounds
03/15/2000CN1247091A Freeze-dired attenuated live vaccine for hepatitis A and its preparing process
03/15/2000CN1247090A Infectious cloacal bursa virus vaccine for chicken and its preparing process and application
03/15/2000CN1050302C Chicken anaemia agent vaccine
03/14/2000US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/14/2000US6037455 Propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels
03/14/2000US6037454 Humanized anti-CD11a antibodies
03/14/2000US6037448 Chimeric viral protein with human lymphocyte determinant; for vaccine development against infection
03/14/2000US6037321 Fusion proteins comprising vasoactive intestinal peptide or PACAP
03/14/2000US6037320 Neurotrophic factor (NT-4)
03/14/2000US6037165 Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6037148 Nucleotide sequence coding mammalian transcription factor polypeptide; for the treatment of diseases associated with loss of tissue stability
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6037135 Methods for making HLA binding peptides and their uses
03/14/2000US6036978 Antiinflammatory agents for gastrointestinal disorders
03/14/2000US6036961 Immunogenic antigens of giardia cultures in bile
03/14/2000US6036960 Filamentous hemagglutinin of B. pertussis
03/14/2000US6036959 HCMV/HSV fusion glycoproteins
03/14/2000US6036958 Tsetse thrombin inhibitor
03/14/2000US6036957 Immunology suppression with cd4 and t-cells reactive with mylin protein
03/14/2000US6036956 Method and dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease
03/14/2000US6036953 Dna encoding with escherichia coli and fusion polypeptides
03/14/2000CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof
03/14/2000CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
03/14/2000CA2071205C Cell surface antigen associated with cellular apoptosis
03/14/2000CA2010177C Purified mite allergen
03/14/2000CA2008817C M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
03/14/2000CA1340926C Human rhinovirus peptides
03/14/2000CA1340924C Structural phosphoprotein (pp 150) of human cytomegalovirus, and the preparation thereof
03/09/2000WO2000012758A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012728A1 Expression of clostridial toxins and proteins
03/09/2000WO2000012718A1 Superoxide dismutase as a vaccine antigen
03/09/2000WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012700A1 GENE ENCODING CDw108
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000WO2000012684A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
03/09/2000WO2000012678A2 Staphylococcus aureus genes and polypeptides
03/09/2000WO2000012677A2 Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
03/09/2000WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES
03/09/2000WO2000012558A1 Human monoclonal antibodies directed against the islet cell antigen ia-2
03/09/2000WO2000012556A1 High-affinity antibodies
03/09/2000WO2000012550A1 Novel polypeptide
03/09/2000WO2000012549A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000WO2000012548A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
1 ... 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 ... 1823